Back to Search Start Over

[A favorable clinical course of acute myeloid leukemia with t (6;21;8)(p23;q22;q22)]

Authors :
Atsushi, Wada
Noriko, Doki
Yuki, Otsuka
Hiroto, Adachi
Ryosuke, Konuma
Yuya, Kishida
Tatsuya, Konishi
Yuta, Yamada
Akihito, Nagata
Ryohei, Nagata
Atsushi, Marumo
Yuma, Noguchi
Junichi, Mukae
Takashi, Toya
Aiko, Igarashi
Yuho, Najima
Takeshi, Kobayashi
Hironori, Harada
Yuka, Harada
Hisashi, Sakamaki
Kazuteru, Ohashi
Source :
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(2)
Publication Year :
2022

Abstract

Variants of the t (8;21) (q22;q22) involving chromosome 8, 21, and other chromosomes account for about 3% of all t (8;21) (q22;q22) in patients with acute myeloid leukemia (AML). However, the prognosis of AML with variant t (8;21) remains unknown due to the scarcity of reported cases. Herein we report a case of AML with t (6;21;8) (p23;q22;q22). Fluorescence in situ hybridization confirmed a RUNX1-RUNX1T1 fusion signal on the derivative chromosome 8. This is the first report on a variant of t (8;21) involving the breakpoint 6p23. After induction chemotherapy, our patient achieved complete remission and has been stable for four years.

Details

ISSN :
04851439
Volume :
63
Issue :
2
Database :
OpenAIRE
Journal :
[Rinsho ketsueki] The Japanese journal of clinical hematology
Accession number :
edsair.pmid..........e1c63b55e1e1a217a6d515edb5f69609